Ryvu Therapeutics S.A. (WSE:RVU)
Poland · Delayed Price · Currency is PLN 15.00
-0.12 (-0.79%)
Jul 24, 2026, 5:00 PM CET
Ryvu Therapeutics Income Statement
Financials in millions PLN. Fiscal year is January - December.
Millions PLN. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 88.41 | 87.73 | 102.05 | 67.99 | 70.49 | 36.13 | |
Revenue Growth (YoY) | -9.40% | -14.03% | 50.08% | -3.54% | 95.08% | -3.20% |
Gross Profit | 88.41 | 87.73 | 102.05 | 67.99 | 70.49 | 36.13 |
Depreciation & Amortization Expenses | 9.17 | 9.44 | 10.5 | 10.97 | 12.9 | 12.56 |
Other Operating Expenses | 0.2 | 175.5 | 213.52 | 154.4 | 127.08 | 102.46 |
Total Operating Expenses | 9.37 | 184.95 | 224.02 | 165.37 | 139.98 | 115.02 |
Operating Income | -82.08 | -107.61 | -122.1 | -100.95 | -78.42 | -78.6 |
Interest Income | - | 15.27 | 15.98 | 13.83 | 1.15 | 0.08 |
Interest Expense | - | -8.8 | -5.02 | -5 | -1.92 | -0.44 |
Other Non-Operating Income (Expense) | - | -10.4 | -0.13 | -3.57 | -8.93 | 0.29 |
Total Non-Operating Income (Expense) | - | -3.93 | 10.83 | 5.26 | -9.7 | -0.08 |
Pretax Income | -82.08 | -101.14 | -111.14 | -92.11 | -79.2 | -78.96 |
Provision for Income Taxes | - | 0.09 | 0.3 | 0 | 4.59 | 0.12 |
Net Income | -82.08 | -101.23 | -111.44 | -92.11 | -83.78 | -79.08 |
Net Income to Common | -88.6 | -101.23 | -111.44 | -92.11 | -83.78 | -79.08 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 23 | 23 | 23 | 23 | 18 | 18 |
Shares Outstanding (Diluted) | 23 | 23 | 23 | 23 | 18 | 18 |
Shares Change (YoY) | - | - | 0.97% | 24.75% | - | 9.48% |
EPS (Basic) | -3.79 | -4.40 | -4.80 | -4.00 | -4.60 | -4.30 |
EPS (Diluted) | -3.79 | -4.40 | -4.80 | -4.00 | -4.60 | -4.30 |
EPS Growth | - | - | - | - | - | - |
Free Cash Flow | -100.17 | -121.57 | -135.38 | -93.13 | 19.8 | -70.87 |
Free Cash Flow Growth | - | - | - | - | - | - |
Free Cash Flow Per Share | -4.33 | -5.26 | -5.86 | -4.07 | 1.08 | -3.86 |
Gross Margin | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
Operating Margin | -92.84% | -122.65% | -119.65% | -148.47% | -111.25% | -217.52% |
Profit Margin | -92.84% | -115.38% | -109.20% | -135.47% | -118.86% | -218.85% |
FCF Margin | -113.30% | -138.57% | -132.67% | -136.97% | 28.09% | -196.13% |
EBITDA | -72.5 | -97.75 | -111.6 | -89.98 | -65.52 | -66.04 |
EBITDA Margin | -82.00% | -111.42% | -109.36% | -132.33% | -92.95% | -182.76% |
EBIT | -82.08 | -107.61 | -122.1 | -100.95 | -78.42 | -78.6 |
EBIT Margin | -92.84% | -122.65% | -119.65% | -148.47% | -111.25% | -217.52% |
Effective Tax Rate | - | -0.09% | -0.27% | 0.00% | -5.79% | -0.15% |